Literature DB >> 22735307

Limb ischemia protects against contrast-induced nephropathy.

Joseph V Bonventre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735307      PMCID: PMC3574167          DOI: 10.1161/CIRCULATIONAHA.112.119701

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  26 in total

Review 1.  Kidney ischemic preconditioning.

Authors:  Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-01       Impact factor: 2.894

2.  Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment.

Authors:  K M Park; A Chen; J V Bonventre
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

3.  Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney.

Authors:  Kwon Moo Park; Ji-Yeon Byun; Cornelis Kramers; Jee In Kim; Paul L Huang; Joseph V Bonventre
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

4.  Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).

Authors:  Fikret Er; Amir M Nia; Henning Dopp; Martin Hellmich; Kristina M Dahlem; Evren Caglayan; Torsten Kubacki; Thomas Benzing; Erland Erdmann; Volker Burst; Natig Gassanov
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

5.  Gentamicin increases renal susceptibility to an acute ischemic insult.

Authors:  R A Zager; H M Sharma
Journal:  J Lab Clin Med       Date:  1983-05

6.  Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction.

Authors:  Kwon Moo Park; Cornelis Kramers; Muriel Vayssier-Taussat; Ang Chen; Joseph V Bonventre
Journal:  J Biol Chem       Date:  2001-11-05       Impact factor: 5.157

7.  Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.

Authors:  K Przyklenk; B Bauer; M Ovize; R A Kloner; P Whittaker
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

8.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

9.  Responses of the ischemic acute renal failure kidney to additional ischemic events.

Authors:  R A Zager; L A Baltes; H M Sharma; M S Jurkowitz
Journal:  Kidney Int       Date:  1984-11       Impact factor: 10.612

10.  The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans.

Authors:  Igor E Konstantinov; Sara Arab; Rajesh K Kharbanda; Jia Li; Michael M H Cheung; Vera Cherepanov; Gregory P Downey; Peter P Liu; Eva Cukerman; John G Coles; Andrew N Redington
Journal:  Physiol Genomics       Date:  2004-08-10       Impact factor: 3.107

View more
  4 in total

Review 1.  Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Authors:  Zhangsuo Liu; Rujun Gong
Journal:  Am J Kidney Dis       Date:  2015-08-10       Impact factor: 8.860

2.  Acute kidney injury: Can remote ischaemic preconditioning prevent AKI?

Authors:  Anna Zuk; Joseph V Bonventre
Journal:  Nat Rev Nephrol       Date:  2015-07-28       Impact factor: 28.314

Review 3.  Recent advances in the understanding of acute kidney injury.

Authors:  Florian Tögel; Christof Westenfelder
Journal:  F1000Prime Rep       Date:  2014-09-04

4.  Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase.

Authors:  Feng Wang; Jianyong Yin; Zeyuan Lu; Guangyuan Zhang; Junhui Li; Tao Xing; Shougang Zhuang; Niansong Wang
Journal:  EBioMedicine       Date:  2016-05-18       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.